Megan S. Lim

发表

Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome

J. Byrd, K. Elenitoba-Johnson, M. Lim, 2015, Nature Communications.

NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma

K. Elenitoba-Johnson, M. Lim, A. Sciallis, 2017, Oncogene.

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.

K. Elenitoba-Johnson, M. Lim, L. Medeiros, 2014, Blood.

Updates in pathobiological aspects of anaplastic large cell lymphoma

Rui Wu, Megan S. Lim, Megan S. Lim, 2023, Frontiers in oncology.

NPM-ALK signals through glycogen synthase kinase 3β to promote oncogenesis

K. Elenitoba-Johnson, M. Lim, Zihua Zeng, 2012, Oncogene.

The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways.

P. Szankasi, S. Tripp, K. Elenitoba-Johnson, 2009, Blood.

Comparative Microarray Analysis of Gene Expression During Activation of Human Peripheral Blood T Cells and Leukemic Jurkat T Cells

K. Elenitoba-Johnson, M. Lim, Zhaosheng Lin, 2003, Laboratory Investigation.

Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation

K. Elenitoba-Johnson, M. Lim, X. Chen, 2014, Oncogene.

Immunomodulator agent-related lymphoproliferative disorders

N. Harris, S. Perkins, M. Lim, 2009, Modern Pathology.

A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.

K. Elenitoba-Johnson, M. Lim, L. Medeiros, 2014, Blood.